this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

BTN

BIOTIN

BTN is found in 99 entries

BTN in polymers: 9 entries. Examples include: 4Q6S 1VQN 4Q94

BTN as free ligands, exist in 90 entries. Example includes: 2IZI 1N43 3IB9

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

NameBIOTIN
Identifiers5-[(3aS,4S,6aR)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
FormulaC10 H16 N2 O3 S
Molecular Weight244.31 g/mol
TypeNON-POLYMER
Isomeric SMILESOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12
InChIInChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1
InChIKeyYBJHBAHKTGYVGT-ZKWXMUAHSA-N

Chemical Details

Formal Charge0
Atom Count32
Chiral Atom Count3
Chiral AtomsC2,C4,C5
Bond Count33
Aromatic Bond Count0
Leaving AtomsO12,HO2

Drug Info: DrugBank

DrugBank IDDB00121 Different stereochemistry
NameBiotin
Groups
  • approved
  • nutraceutical
DescriptionA water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. [PubChem]
Synonyms
  • (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid
  • (3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid
  • 5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid
  • Biotin
  • Biotina
Brand Names
  • Acti-biotin 300 Caplet 300mcg
  • Am Caps
  • B 50 Capsules
  • B Complex 25mg Vitamin Supplement
  • B Complex 50 V
Affected OrganismHumans and other mammals
IndicationFor nutritional supplementation, also for treating dietary shortage or imbalance.
PharmacologyBiotin is a water-soluble B-complex vitamin which is composed of an ureido ring fused with a tetrahydrothiophene ring. A valeric acid substituent is attached to one of the carbon atoms of the tetrahydrothiophene ring. Biotin is used in cell growth, the production of fatty acids, metabolism of fats, and amino acids. It plays a role in the Kreb cycle, which is the process in which energy is released from food. Biotin not only assists in various metabolic chemical conversions, but also helps with the transfer of carbon dioxide. Biotin is also helpful in maintaining a steady blood sugar level. Biotin is often recommended for strengthening hair and nails. Consequenty, it is found in many cosmetic and health products for the hair and skin. Biotin deficiency is a rare nutritional disorder caused by a deficiency of biotin. Initial symptoms of biotin deficiency include: Dry skin, Seborrheic dermatitis, Fungal infections, rashes including erythematous periorofacial macular rash, fine and brittle hair, and hair loss or total alopecia. If left untreated, neurological symptoms can develop, including mild depression, which may progress to profound lassitude and, eventually, to somnolence; changes in mental status, generalized muscular pains (myalgias), hyperesthesias and paresthesias. The treatment for biotin deficiency is to simply start taking some biotin supplements. A lack of biotin in infants will lead to a condition called seborrheic dermatitis or "cradle cap". Biotin deficiencies are extremely rare in adults but if it does occur, it will lead to anemia, depression, hair loss, high blood sugar levels, muscle pain, nausea, loss of appetite and inflamed mucous membranes.
Mechanism of actionBiotin is necessary for the proper functioning of enzymes that transport carboxyl units and fix carbon dioxide, and is required for various metabolic functions, including gluconeogenesis, lipogenesis, fatty acid biosynthesis, propionate metabolism, and catabolism of branched-chain amino acids.
Route of administration
  • Intravenous
  • Oral
  • Topical
Categories
  • Alimentary Tract and Metabolism
  • Azoles
  • Chemical Actions and Uses
  • Coenzymes
  • Diet, Food, and Nutrition
ATC-CodeA11HA05
AHFS-Code88:08.00
CAS number58-85-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682